Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
Ben TranJose M Ruiz-MoralesEnrique Gonzalez-BillalabeitiaAnna PatrikidouEitan AmirChristoph SeidelCarsten BokemeyerChristian FankhauserThomas HermannsAlexey RumyantsevAlexey TryakinMargarida BritoAude FléchonEdmond Michael KwanTina ChengDaniel CastellanoXavier Garcia Del MuroAnis A HamidMargaret OttavianoGiovannella PalmieriRobert KitsonAlison ReidDaniel Y C HengPhilippe L BedardPublished in: Cancer medicine (2019)
Large RPLN and VAD use are independent risk factors for VTE in mGCT patients receiving chemotherapy. VAD use should be minimized in this population and thromboprophylaxis might be considered for large RPLN.